| Name | Title | Contact Details |
|---|
Cergis Billing is a Dallas, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Nanoscale Combinatorial Synthesis, Inc. is a Menlo Park, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
For nearly 30 years, Press Ganey`s mission has been to support health care providers in understanding and improving the entire patient experience. As a strategic business partner to more than 10,000 health care organizations across the country and across the continuum of care, we are the leader in helping create continuous, sustainable improvement. Headquartered in South Bend, Indiana, Press Ganey serves clients nationwide with locally based teams of associates to ensure strong client connections and relationships. As a result, Press Ganey is acutely aware of the challenges and opportunities unique to specific providers and their communities. Our associates are professionals, deeply rooted in health care and strongly committed to our clients` success. Whether it`s in the hospital, medical practice, ambulatory or home care setting, we partner with clients to create and sustain a high-performance environment to ultimately improve the patient experience. Our comprehensive suite of health care solutions helps clients meet their goals of improved quality, better care and lower costs. Press Ganey provides both ongoing advisory services and consulting in all phases of performance improvement. Our patient experience advisors are uniquely trained and skilled to identify areas of opportunity and help clients implement targeted improvement plans. Our consultants, whose health care experience is a true differentiator, work in partnership with organizations to identify and implement best practices across their operations. Simply put, we are vested in our clients` success, and dedicated to helping understand and improve every dimension of the patient experience.
lcelyx was founded in 2010 with venture capital backing based on Gut Sensory Modulation (GSM) technology. Elcelyx`s proprietary, first-in-class Gut Sensory Modulators are delivered directly to the lower gut where they act on molecular targets to elicit physiological and pharmacological effects. The Elcelyx proprietary product candidate, NewMet for Type 2 diabetes is entering Phase 2b development and is a blockbuster opportunity designed to address the unmet needs in the oral anti-diabetic market. Elcelyx is led by an experienced management team and Board of Directors with track records of success in drug development and commercialization. Premier investors along with seasoned scientists and clinicians support the team. In September 2013, Elcelyx announced the formation of NaZura BioHealth Inc, a separate company established to focus on the development on non-NewMet assets.
Canyon House & Crescent Villa is a Sunnyvale, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.